Evaluating the effectiveness of antidepressant therapy adjuvant to gabapentin and pregabalin for treatment of SCI-related neuropathic pain.
Emily Carol McKinleyElizabeth J RichardsonGerald McGwinJie ZhangPublished in: The journal of spinal cord medicine (2018)
The initiation of a combination of anticonvulsant and antidepressant shortly after SCI was not associated with improved pain control at 6 months compared to individual therapy. Adherent patients reported lower levels of pain; further analysis is warranted to elucidate this association.
Keyphrases
- neuropathic pain
- spinal cord injury
- spinal cord
- end stage renal disease
- major depressive disorder
- newly diagnosed
- ejection fraction
- randomized controlled trial
- chronic kidney disease
- systematic review
- early stage
- peritoneal dialysis
- prognostic factors
- stem cells
- pain management
- patient reported outcomes
- bone marrow
- replacement therapy
- patient reported
- postoperative pain